Hematology (all articles)

Study: Chemotherapy for Solid Tumors Associated with Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia

3 Jan, 2019 | 11:25h | UTC

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era – JAMA Oncology (link to abstract – $ for full-text)

Commentary: Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors – NIH News Releases (free)

 

---

Meta-Analysis: The Global Burden of Sickle Cell Disease in Children Under Five Years of Age

3 Jan, 2019 | 11:14h | UTC

The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis – Journal of Global Health (free)

 

---

Review: Antiphospholipid Syndrome and the Neurologist

13 Dec, 2018 | 18:44h | UTC

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy – Frontiers in Neurology (free)

 

---

ASCO Guideline Endorsement Summary: Initial Diagnostic Workup of Acute Leukemia

13 Dec, 2018 | 18:09h | UTC

Initial Diagnostic Workup of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement Summary of the CAP and ASH Guideline – Journal of Oncology Practice (free)

 

---

Consensus Report: Evaluation of Monoclonal Gammopathy of Renal Significance

13 Dec, 2018 | 18:04h | UTC

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group – Nature Reviews Nephrology (free)

 

---

tudy: Axicabtagene Ciloleucel in Refractory Large B-cell Lymphoma

3 Dec, 2018 | 23:41h | UTC

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial – The Lancet Oncology (free)

Commentary: ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial – eCancer News (free)

 

---

Study: Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3 Dec, 2018 | 23:40h | UTC

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma – New England Journal of Medicine (free)

See also: ASH 2018: Updated Analysis of JULIET Trial: Tisagenlecleucel in Relapsed or Refractory DLBCL – The ASCO Post (free)

 

---

Randomized Trial: Ibrutinib Regimens vs. Chemoimmunotherapy in Older Patients with Untreated CLL

3 Dec, 2018 | 23:39h | UTC

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL – New England Journal of Medicine (free)

Commentary: ASH 2018: Ibrutinib Alone or in Combination With Rituximab vs Bendamustine Plus Rituximab in Older Patients With CLL – The ASCO Post (free)

 

---

Study: Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

2 Dec, 2018 | 23:28h | UTC

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa – New England Journal of Medicine (free)

Commentaries: Studies Show Improved Sickle Cell Disease Outcomes Worldwide – American Society of Hematology (free) AND ASH 2018: Large Single-Arm Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa – The ASCO Post (free) AND Sickle cell anemia treatment safely lowers disease burden in African children – Cincinnati Children’s Hospital Medical Center (free) AND ‘From Nothing to Gangbusters’: A Treatment for Sickle-Cell Disease Proves Effective in Africa – New England Journal of Medicine (10 articles per month are free)

 

---

Guideline: Diagnosis and Management of Polycythaemia Vera

30 Nov, 2018 | 02:51h | UTC

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline (free)

 

---

New ASH Clinical Practice Guidelines on Venous Thromboembolism

30 Nov, 2018 | 02:53h | UTC

ASH Clinical Practice Guidelines on Venous Thromboembolism – American Society of Hematology (free)

News Release: New clinical practice guidelines for venous thromboembolism (free)

 

---

Systematic Review: Effect of Testing for Cancer in People with Unprovoked VTE

30 Nov, 2018 | 01:46h | UTC

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE – Cochrane Library (free)

Summary: Effect of testing for cancer (on cancer and blood clot-related death and illness) in people with unprovoked blood clots in the legs and lungs – Cochrane Library (free)

 

---

Review: Antithrombotic Therapies for Elderly Patients

30 Nov, 2018 | 01:35h | UTC

Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities – Clinical Interventions in Aging (free)

 

---

Aplastic Anemia: Etiology, Molecular Pathogenesis, and Emerging Concepts

30 Nov, 2018 | 01:30h | UTC

Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts – European Journal of Haematology (free)

 

---

Review: Peripheral Nervous System Involvement in Lymphoproliferative Disorders

30 Nov, 2018 | 01:21h | UTC

Peripheral Nervous System Involvement in Lymphoproliferative Disorders – Mediterranean Journal of Hematology and Infectious Diseases (free)

 

---

NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease

25 Nov, 2018 | 20:42h | UTC

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 – Journal of the National Comprehensive Cancer Network (free)

 

---

Multiple myeloma: 2018 Update on Diagnosis, Risk‐Stratification, and Management

25 Nov, 2018 | 20:36h | UTC

Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management – American Journal of Hematology (free)

 

---

Guideline: First-Line Treatment of Chronic Lymphocytic Leukemia

25 Nov, 2018 | 20:19h | UTC

Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia – Current Oncology (free)

 

---

Guideline: Diagnosis and Management of Primary Central Nervous System Diffuse Large B‐cell lymphoma

25 Nov, 2018 | 20:13h | UTC

Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma – British Society for Haematology (free)

 

---

Systematic Review: Clinical Outcomes Associated With Sickle Cell Trait

17 Nov, 2018 | 23:39h | UTC

Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Links between SCT and adverse outcomes – HematologyTimes (free)

 

---

Review: Interruption and Reversal of Direct Oral Anticoagulants in Preprocedural and Acute Settings

16 Nov, 2018 | 03:28h | UTC

Interruption and Reversal of Direct Oral Anticoagulants in Preprocedural and Acute Settings – Journal of the American Board of Family Medicine (free)

Source: Medscape

 

---

Randomized Trial: Platelet-Transfusion Thresholds in Neonates

5 Nov, 2018 | 12:10h | UTC

Randomized Trial of Platelet-Transfusion Thresholds in Neonates – New England Journal of Medicine (free)

Commentaries: Lower threshold for platelet transfusions appears safer – HematologyTimes (free)

 

---

Systematic Review: Stroke Prevention in Patients With Atrial Fibrillation

5 Nov, 2018 | 12:05h | UTC

Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update – Agency for Healthcare Research and Quality (free)

Full Report: Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update (free PDF)

 

---

Review: Cancer-Associated Thrombosis

5 Nov, 2018 | 11:51h | UTC

Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment – Cancers (free)

 

---

NICE Guideline: Multiple Myeloma

2 Nov, 2018 | 02:33h | UTC

Myeloma: diagnosis and management – National Institute for Health and Care Excellence (free)

 

---